Displaying items by tag: division of cardiovascular disease

This study highlights how high-volume centers, where operators perform these procedures more frequently, achieve better outcomes, including lower 30-day mortality and reduced complication rates. 
AFib is expected to affect 40 million people worldwide and can be fatal if not treated. UAB experts provide tips on symptoms, risk factors and management of this condition.
Researchers at UAB shed light on the link between genetic variants and cardiovascular risk factors in determining heart health.
This procedure has been clinically proved to help reduce blood pressure in patients for whom neither medications nor lifestyle changes have been successful.
UAB researchers leverage data from the All of Us Research Program to show that carpal tunnel syndrome is a sentinel event for cardiac amyloidosis.
The device will be used to treat patients with symptomatic severe aortic stenosis who are at high or extreme risk for open-heart surgery.
A large nationwide study found that Black individuals carrying a genetic mutation in the TTN gene were at an increased risk of adverse clinical outcomes.
Pulsed-field ablation disrupts the cellular membranes of vein tissue, irreversibly preventing those membranes from conducting electricity. This protects the heart from the rapid impulses which can cause atrial fibrillation.
UAB researchers leverage data from the SPRINT trial to show that intensive control of blood pressure reduces troponin I levels and this decrease in troponin I levels is associated with reduced risk of cardiovascular disease.

Although living with his congenital heart defect has come with its challenges, Bill Wingate hopes he can encourage others with similar conditions. 

A post-hoc analysis of critically ill COVID-19 patients revealed that high-dose inhaled nitric oxide therapy was more beneficial in reducing the risk of mortality in Black patients compared with their white counterparts.
Page 1 of 12